Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator: Results from Phase 1 Single and Multiple Ascending Dose Studies

• Bharat Awsare, M.D.,
• Jason Lerner, M.D.,
• Eric Ashbrenner, M.S.,
• Heather Sevinsky, M.S.,
• Michael Bozik, M.D.,
• Steven Dworetzky, Ph.D.,
• Lia Donahue, M.A.,
• Randall Killingsworth, B.A.,
• Bruno Francoeur, M.D.,
• Irfan Qureshi, M.D.

Affiliations

Bharat Awsare, M.D.

Biohaven Pharmaceuticals

Jason Lerner, M.D.

Biohaven Pharmaceuticals

Eric Ashbrenner, M.S.

Biohaven Pharmaceuticals

Heather Sevinsky, M.S.

Biohaven Pharmaceuticals

Michael Bozik, M.D.

Biohaven Pharmaceuticals

Steven Dworetzky, Ph.D.

Biohaven Pharmaceuticals

Lia Donahue, M.A.

Biohaven Pharmaceuticals

Randall Killingsworth, B.A.

Biohaven Pharmaceuticals

Bruno Francoeur, M.D.

Syneos Health

Irfan Qureshi, M.D.

Biohaven Pharmaceuticals